Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery

NCT00082121 is registered in ClinicalTrials.gov with Avant Immunotherapeutics as lead sponsor.

NCT NCT00082121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00082121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of TP10, a Complement Inhibitor, in Adult Women Undergoing Cardiopulmonary Bypass Surgery
Lead sponsor
Avant Immunotherapeutics
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2004
Completion date
December 31, 2005
Enrollment
300
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve insufficiency, coronary arteriosclerosis, mitral valve insufficiency, myocardial ischemia